Imunovir 500 mg (Inosine Pranobex TABLET) 500 MG

IMUNOVIR 500 MG tablets contain inosine pranobex, an immune-modulating agent. Learn about its uses, effects, and precautions for supporting immune function.

Strength

500 MG

Pack Size

100

Manufacturer / TM Owner

KORA HEALTHCARE

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

IMUNOVIR 500 MG tablets are generally used to support the immune system. Inosine pranobex, the active ingredient, is often explored for its potential to enhance immune response. People may consider this medication for immune support during illness or recovery. Always consult a healthcare provider to understand what is inosine pranobex used for in your specific case.

Side Effects

Common effects of IMUNOVIR 500 MG tablets may include mild gastrointestinal discomfort or headaches. Individual responses can vary, and not everyone will experience these effects. If you notice any persistent or severe symptoms, it's important to seek medical advice.

Precautions & Warnings

IMUNOVIR 500 MG tablets should be handled with care. Store them in a cool, dry place away from direct sunlight. Keep the medication out of reach of children and pets. Always follow the guidance of a healthcare professional regarding the use of inosine pranobex.

Avoid Interactions

IMUNOVIR 500 MG tablets may interact with certain medications, including those metabolized by the liver. Alcohol consumption should be avoided while taking this medication. It's important to inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

IMUNOVIR 500 MG tablets are generally used to support the immune system. The active ingredient, inosine pranobex, is often explored for its potential to enhance immune response.

IMUNOVIR 500 MG tablets are taken orally. Always follow the dosage instructions provided by your healthcare provider.

Common effects may include mild gastrointestinal discomfort or headaches. Individual responses can vary.

It is generally advised to avoid alcohol while taking IMUNOVIR 500 MG tablets to prevent potential interactions.

IMUNOVIR 500 MG tablets may be available from various online pharmacies. Always ensure you are purchasing from a reputable source.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.